Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 19 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-4.39 Insider Own56.64% Shs Outstand43.59M Perf Week-1.49%
Market Cap144.28M Forward P/E- EPS next Y-1.18 Insider Trans-7.49% Shs Float18.90M Perf Month8.88%
Income-69.24M PEG- EPS next Q-0.26 Inst Own45.97% Short Float3.32% Perf Quarter-23.02%
Sales0.00M P/S- EPS this Y50.56% Inst Trans2.60% Short Ratio2.16 Perf Half Y-41.00%
Book/sh1.36 P/B2.43 EPS next Y-13.87% ROA- Short Interest0.63M Perf Year-66.67%
Cash/sh2.29 P/C1.45 EPS next 5Y- ROE- 52W Range2.00 - 14.00 Perf YTD-29.12%
Dividend Est.- P/FCF- EPS past 5Y- ROI-116.71% 52W High-76.36% Beta0.25
Dividend TTM- Quick Ratio4.97 Sales past 5Y0.00% Gross Margin- 52W Low65.50% ATR (14)0.38
Dividend Ex-Date- Current Ratio4.97 EPS Y/Y TTM-2148.09% Oper. Margin0.00% RSI (14)54.92 Volatility13.47% 15.30%
Employees15 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price19.33
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-641.35% Payout- Rel Volume0.83 Prev Close3.69
Sales Surprise- EPS Surprise40.57% Sales Q/Q- EarningsMar 28 BMO Avg Volume291.44K Price3.31
SMA2017.38% SMA501.07% SMA200-32.86% Trades Volume240,674 Change-10.30%
Date Action Analyst Rating Change Price Target Change
Oct-10-23Initiated Ladenburg Thalmann Buy $10
Aug-25-23Initiated Oppenheimer Outperform $17
Jun-22-23Initiated Guggenheim Buy $20
Jun-14-23Initiated Chardan Capital Markets Buy $14
May-24-23Initiated Raymond James Strong Buy $20
Apr-18-24 09:22AM
Apr-08-24 06:00AM
Mar-28-24 11:54AM
Mar-04-24 06:00AM
06:00AM Loading…
Feb-02-24 06:00AM
Jan-08-24 06:00AM
Jan-03-24 06:00AM
Dec-04-23 06:00AM
Nov-14-23 06:00AM
Nov-13-23 06:30AM
Sep-12-23 05:00AM
Sep-05-23 08:55PM
Aug-25-23 09:42AM
Aug-14-23 07:00AM
06:30AM Loading…
Jun-23-23 06:30AM
Jun-06-23 06:34AM
Jun-01-23 10:20AM
Apr-27-23 07:39AM
Apr-14-23 05:00AM
Mar-27-23 09:35AM
Mar-21-23 06:13AM
Zura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thiara ParvinderDirectorDec 12 '23Sale4.002,000,0008,000,0004,801,633Dec 14 03:35 PM
Munshi AmitDirectorJun 05 '23Buy4.25117,647500,000617,640Jun 05 07:15 PM